F. Marseille, Institut Paoli-Calmettes, 232 Bd Ste-Marguerite, 13273 Marseille Cedex 09, France. 3 Centre d'Immunologie Marseille-Luminy, Parc Scientifique & Technologique de Luminy -Case 906 -F13288 Marseille cedex 09, France. 4 Department of Surgery, p.232

. Bd, F. Ste-marguerite-bertucci, P. Finetti, N. Cervera, D. Maraninchi et al., Gene expression profiling and clinical outcome in breast cancer, 58 Bd Charles Livon, pp.429-443, 2006.

T. Sorlie, R. Tibshirani, J. Parker, T. Hastie, J. Marron et al., Repeated observation of breast tumor subtypes in independent gene expression data sets, Proceedings of the National Academy of Sciences, vol.100, issue.14, pp.8418-8423, 2003.
DOI : 10.1073/pnas.0932692100

T. Sørlie, Y. Wang, C. Xiao, H. Johnsen, B. Naume et al., Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms, BMC Genomics, vol.7, issue.1, p.127, 2006.
DOI : 10.1186/1471-2164-7-127

C. Perou, T. Sørlie, M. Eisen, M. Van-de-rijn, S. Jeffrey et al., Molecular portraits of human breast tumours, Nature, vol.406, issue.6797, pp.747-752, 2000.
DOI : 10.1038/35021093

. Van-'t, L. Veer, H. Dai, M. Van-de-vijver, Y. He et al., Gene expression profiling predicts clinical outcome of breast cancer, Nature, vol.415, pp.530-536, 2002.

F. Bertucci, P. Finetti, N. Cervera, B. Esterni, F. Hermitte et al., How basal are triple-negative breast cancers?, International Journal of Cancer, vol.9, issue.1, pp.236-240, 2008.
DOI : 10.1002/ijc.23518

M. Van-de-vijver, Y. He, . Van-'t, L. Veer, H. Dai et al., A Gene-Expression Signature as a Predictor of Survival in Breast Cancer, New England Journal of Medicine, vol.347, issue.25, pp.1999-2009, 2002.
DOI : 10.1056/NEJMoa021967

C. Desmedt, B. Haibe-kains, P. Wirapati, M. Buyse, D. Larsimont et al., Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes, Clinical Cancer Research, vol.14, issue.16, pp.5158-5165, 2008.
DOI : 10.1158/1078-0432.CCR-07-4756

G. Manning, D. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam, The Protein Kinase Complement of the Human Genome, Science, vol.298, issue.5600, pp.1912-1934, 2002.
DOI : 10.1126/science.1075762

P. Futreal, L. Coin, M. Marshall, T. Down, T. Hubbard et al., A census of human cancer genes, Nature Reviews Cancer, vol.4, issue.3, pp.177-83, 2004.
DOI : 10.1038/nrc1299

D. Krause and R. Van-etten, Tyrosine Kinases as Targets for Cancer Therapy, New England Journal of Medicine, vol.353, issue.2, pp.172-187, 2005.
DOI : 10.1056/NEJMra044389

P. Finetti, N. Cervera, E. Charafe-jauffret, C. Chabannon, C. Charpin et al., Sixteen-Kinase Gene Expression Identifies Luminal Breast Cancers with Poor Prognosis, Cancer Research, vol.68, issue.3, pp.767-776, 2008.
DOI : 10.1158/0008-5472.CAN-07-5516

C. Speers, A. Tsimelzon, K. Sexton, A. Herrick, C. Gutierrez et al., Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor-Negative Breast Cancer, Clinical Cancer Research, vol.15, issue.20, pp.6327-6340, 2009.
DOI : 10.1158/1078-0432.CCR-09-1107

. Sabatier, Molecular Cancer http://www.molecular-cancer.com/content, p.8686, 2011.

M. Schmidt, D. Böhm, C. Von-törne, E. Steiner, A. Puhl et al., The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer, Cancer Research, vol.68, issue.13, pp.5405-5413, 2008.
DOI : 10.1158/0008-5472.CAN-07-5206

Y. Wang, J. Klijn, Y. Zhang, A. Sieuwerts, M. Look et al., Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer, The Lancet, vol.365, issue.9460, pp.671-679, 2005.
DOI : 10.1016/S0140-6736(05)70933-8

C. Sotiriou, P. Wirapati, S. Loi, A. Harris, S. Fox et al., Gene Expression Profiling in Breast Cancer: Understanding the Molecular Basis of Histologic Grade To Improve Prognosis, JNCI Journal of the National Cancer Institute, vol.98, issue.4, pp.262-272, 2006.
DOI : 10.1093/jnci/djj052

A. Ivshina, J. George, O. Senko, B. Mow, T. Putti et al., Genetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer, Cancer Research, vol.66, issue.21, pp.10292-10301, 2006.
DOI : 10.1158/0008-5472.CAN-05-4414

C. Desmedt, F. Piette, S. Loi, Y. Wang, F. Lallemand et al., Strong Time Dependence of the 76-Gene Prognostic Signature for Node-Negative Breast Cancer Patients in the TRANSBIG Multicenter Independent Validation Series, Clinical Cancer Research, vol.13, issue.11, pp.3207-3214, 2007.
DOI : 10.1158/1078-0432.CCR-06-2765

Y. Pawitan, J. Bjöhle, L. Amler, A. Borg, S. Egyhazi et al., Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts, Breast Cancer Research, vol.7, issue.6, pp.953-964, 2005.
DOI : 10.1186/bcr1325

L. Miller, J. Smeds, J. George, V. Vega, L. Vergara et al., From The Cover: An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival, Proceedings of the National Academy of Sciences, vol.102, issue.38, pp.13550-13555, 2005.
DOI : 10.1073/pnas.0506230102

K. Hess, K. Anderson, W. Symmans, V. Valero, N. Ibrahim et al., Pharmacogenomic Predictor of Sensitivity to Preoperative Chemotherapy With Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide in Breast Cancer, Journal of Clinical Oncology, vol.24, issue.26, pp.4236-4244, 2006.
DOI : 10.1200/JCO.2006.05.6861

H. Bonnefoi, A. Potti, M. Delorenzi, L. Mauriac, M. Campone et al., RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial, The Lancet Oncology, vol.8, issue.12, pp.1071-1078, 2007.
DOI : 10.1016/S1470-2045(07)70345-5

C. Theillet, A. J. Louason, G. Bonnet-dorion, F. Jacquemier, J. Adnane et al., FGFRI andPLAT genes and DNA amplification at 8p 12 in breast and ovarian cancers, Genes, Chromosomes and Cancer, vol.4, issue.4, pp.219-226, 1993.
DOI : 10.1002/gcc.2870070407

R. Irizarry, B. Hobbs, C. F. Beazer-barclay, Y. Antonellis, K. Scherf et al., Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, vol.4, issue.2, pp.249-264, 2003.
DOI : 10.1093/biostatistics/4.2.249

Z. Hu, C. Fan, D. Oh, J. Marron, X. He et al., CM: The molecular portraits of breast tumors are conserved across microarray platforms, BMC Genomics, vol.7, issue.1, p.96, 2006.
DOI : 10.1186/1471-2164-7-96

A. Rosenwald, G. Wright, W. Chan, J. Connors, E. Campo et al., The Use of Molecular Profiling to Predict Survival after Chemotherapy for Diffuse Large-B-Cell Lymphoma, New England Journal of Medicine, vol.346, issue.25, pp.1937-1947, 2002.
DOI : 10.1056/NEJMoa012914

A. Rody, U. Holtrich, L. Pusztai, C. Liedtke, R. Gaetje et al., T-cell metagene predicts a favorable prognosis in estrogen receptor-negative and HER2-positive breast cancers, Breast Cancer Research, vol.10, issue.2, p.15, 2009.
DOI : 10.1186/bcr2124

E. Davicioni, J. Anderson, J. Buckley, W. Meyer, and T. Triche, Gene Expression Profiling for Survival Prediction in Pediatric Rhabdomyosarcomas: A Report From the Children's Oncology Group, Journal of Clinical Oncology, vol.28, issue.7, pp.1240-1246, 2010.
DOI : 10.1200/JCO.2008.21.1268

G. Lenz, G. Wright, S. Dave, X. W. Powell, J. Zhao et al., Stromal Gene Signatures in Large-B-Cell Lymphomas, New England Journal of Medicine, vol.359, issue.22, pp.2313-2323, 2008.
DOI : 10.1056/NEJMoa0802885

F. Bertucci, N. Borie, H. Roche, T. Bachelot, L. Doussal et al., Gene expression profile predicts outcome after anthracycline-based adjuvant chemotherapy in early breast cancer, Breast Cancer Research and Treatment, vol.23, issue.Suppl 3, pp.363-373, 2011.
DOI : 10.1007/s10549-010-1003-z
URL : https://hal.archives-ouvertes.fr/hal-00594464

M. Eisen, P. Spellman, P. Brown, and D. Botstein, Cluster analysis and display of genome-wide expression patterns, Proceedings of the National Academy of Sciences, vol.95, issue.25, pp.14863-14868, 1998.
DOI : 10.1073/pnas.95.25.14863

R. Sabatier, P. Finetti, N. Cervera, E. Lambaudie, B. Esterni et al., A gene expression signature identifies two prognostic subgroups of basal breast cancer, Breast Cancer Research and Treatment, vol.280, issue.3, pp.407-420, 2011.
DOI : 10.1007/s10549-010-0897-9
URL : https://hal.archives-ouvertes.fr/hal-00583558

J. Staaf, M. Ringnér, J. Vallon-christersson, G. Jönsson, P. Bendahl et al., Identification of Subtypes in Human Epidermal Growth Factor Receptor 2???Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome, Journal of Clinical Oncology, vol.28, issue.11, pp.1813-1820, 2010.
DOI : 10.1200/JCO.2009.22.8775

C. Palmer, M. Diehn, A. Alizadeh, and P. Brown, Cell-type specific gene expression profiles of leukocytes in human peripheral blood, BMC Genomics, vol.7, issue.1, p.115, 2006.
DOI : 10.1186/1471-2164-7-115

A. Subramanian, P. Tamayo, V. Mootha, S. Mukherjee, B. Ebert et al., Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles, Proceedings of the National Academy of Sciences, vol.102, issue.43, pp.15545-15550, 2005.
DOI : 10.1073/pnas.0506580102

L. Mcshane, D. Altman, W. Sauerbrei, S. Taube, M. Gion et al., Reporting Recommendations for Tumor Marker Prognostic Studies, Journal of Clinical Oncology, vol.23, issue.36, pp.9067-9072, 2005.
DOI : 10.1200/JCO.2004.01.0454

C. Sotiriou and M. Piccart, Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care?, Nature Reviews Cancer, vol.97, issue.7, pp.545-553, 2007.
DOI : 10.1200/JCO.2005.04.7985

L. Pusztai, Gene expression profiling of breast cancer, Breast Cancer Research, vol.27, issue.S3, p.11, 2009.
DOI : 10.1200/JCO.2008.21.6887

A. Calabrò, T. Beissbarth, R. Kuner, M. Stojanov, A. Benner et al., Effects of infiltrating lymphocytes and estrogen receptor on gene expression and prognosis in breast cancer, Breast Cancer Research and Treatment, vol.120, issue.6917, pp.69-77, 2009.
DOI : 10.1007/s10549-008-0105-3

A. Teschendorff, A. Miremadi, S. Pinder, I. Ellis, and C. Caldas, An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer, Genome Biology, vol.8, issue.8, p.157, 2007.
DOI : 10.1186/gb-2007-8-8-r157

A. Teschendorff and C. Caldas, A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer, Breast Cancer Research, vol.66, issue.4, p.73, 2008.
DOI : 10.1158/0008-5472.CAN-06-0031

G. Alexe, G. Dalgin, D. Scanfeld, P. Tamayo, J. Mesirov et al., High Expression of Lymphocyte-Associated Genes in Node-Negative HER2+ Breast Cancers Correlates with Lower Recurrence Rates, Cancer Research, vol.67, issue.22, pp.10669-10676, 2007.
DOI : 10.1158/0008-5472.CAN-07-0539

B. Kreike, M. Van-kouwenhove, H. Horlings, B. Weigelt, H. Peterse et al., Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas, Breast Cancer Research, vol.161, issue.5, p.65, 2007.
DOI : 10.1016/S0002-9440(10)64476-8

. Sabatier, Molecular Cancer http://www.molecular-cancer.com/content, p.8686, 2011.

F. Bertucci, P. Finetti, N. Cervera, E. Charafe-jauffret, M. Buttarelli et al., How different are luminal A and basal breast cancers?, International Journal of Cancer, vol.1, issue.6, pp.1338-1348, 2009.
DOI : 10.1002/ijc.24055

M. Disis and K. Park, Immunomodulation of Breast Cancer via Tumor Antigen Specific Th1, Cancer Research and Treatment, vol.41, issue.3, pp.117-121, 2009.
DOI : 10.4143/crt.2009.41.3.117

E. Charafe-jauffret, C. Ginestier, F. Monville, P. Finetti, J. Adélaïde et al., Gene expression profiling of breast cell lines identifies potential new basal markers, Oncogene, vol.109, issue.15, pp.2273-2284, 2006.
DOI : 10.1038/sj.onc.1209254
URL : https://hal.archives-ouvertes.fr/hal-01431970

M. Disis, Immune Regulation of Cancer, Journal of Clinical Oncology, vol.28, issue.29, pp.4531-5438, 2010.
DOI : 10.1200/JCO.2009.27.2146

M. Disis, H. Bernhard, and E. Jaffee, Use of tumour-responsive T cells as cancer treatment, The Lancet, vol.373, issue.9664, pp.673-683, 2009.
DOI : 10.1016/S0140-6736(09)60404-9